US 12226429
Highly active compounds against COVID-19
granted A61KA61K31/706A61K31/7064
Quick answer
US patent 12226429 (Highly active compounds against COVID-19) held by Atea Pharmaceuticals, Inc. expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Atea Pharmaceuticals, Inc.
- Grant date
- Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/706, A61K31/7064, A61K31/7076, A61K9/0019